Log in to save to my catalogue

HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downre...

HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932309068

HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway

About this item

Full title

HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway

Publisher

Athens: D.A. Spandidos

Journal title

International journal of oncology, 2016-12, Vol.49 (6), p.2529-2537

Language

English

Formats

Publication information

Publisher

Athens: D.A. Spandidos

More information

Scope and Contents

Contents

Multidrug resistance (MDR) plays a pivotal role in human chronic myelogenous leukemia (CML) chemotherapy failure. MDR is mainly associated with the overexpression of drug efflux transporters of the ATP-binding cassette (ABC) proteins. Phosphoinositide 3-kinase (PI3K)/Akt signaling cascade is involved in the MDR phenotype and is correlated with mult...

Alternative Titles

Full title

HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1932309068

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1932309068

Other Identifiers

ISSN

1019-6439

E-ISSN

1791-2423

DOI

10.3892/ijo.2016.3738

How to access this item